Clinical Trials Browser

Terminated × Carcinoma, Non-Small-Cell Lung × Ramucirumab × Clear all

NCT05062980 2025-02-20

Acclaim-2

Phase 1/2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT03904108 2022-05-26

Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy

Phase 2 Terminated

3 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung